ArticleMolecules (Basel, Switzerland)2019

A Peptide-Based HIV-1 Fusion Inhibitor with Two Tail-Anchors and Palmitic Acid Exhibits Substantially Improved In Vitro and Ex Vivo Anti-HIV-1 Activity and Prolonged In Vivo Half-Life.

Shan Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.